ovarian cancer

By Jonah Comstock 11:36 am December 7, 2015
French companion app company Voluntis has partnered with AstraZeneca to develop an app for women undergoing treatment for ovarian cancer. Specifically, the app will help patients and clinicians manage the side effects of a combination therapy of the drugs cediranib and olaparib, which can cause hypertension and diarrhea. "AstraZeneca has a strong focus on the use of companion devices in drug...